Alkem Laboratories Ltd.

Purpose: To drive innovation for organization in multiple faceted manner- creating in-house intellectual property using tools of basic research & repurposing, creating partnership & collaborating with world-class leading universities, academia and small-to-mid size novel research companies in US, EU and other key countries. Thus generate highest level of value-proposition for the organization in most cost-efficient manner. Drive excellence in strategy, planning and execution of activities for supporting organization through various processes of target optimization, translational drug development, rounded clinical development for regulatory approval and successful launches. As CEO of Proprietary Entity - Alixer Nexgen Therapeutics Ltd, to bring excellence in proprietary product business through unique model and strategy, planning and execution of activities for supporting organization based on processes of collaborative proprietary novel product R&D, partrnerships with centers of innovation excellence, global development & commercialization strategies with successful business partnerships for driving proprietary business. Creating & strengthening intellectual property to drive proprietary product value proposition across all areas of small molecules, large molecules and disruptive cell & gene therapies. Along-with, driving Global Clinical research & development, Medical affairs, Pharmacovigilance thereby bringing shared success for organization. Differentiated medico-marketing strategies supported by market access & pharmacoeconomics plans and execution with medical affairs as 'Partner in Business Success' at all levels through passion and strong ownership model for medical Affairs. Through best practices in pharmacovigilance, ensure risk free environment through higher standards of drug safety and patient centricity. Bring innovation in pipe-line creation and strategic deployment through effective development activities.

In the role of Sr. General Manager & Chief Information Security Officer at Alkem Laboratories Ltd., overseeing digital transformation & cybersecurity strategy across multiple subsidiaries has been both challenging and rewarding. Leading cybersecurity operations for seven subsidiaries allowed for the creation of a comprehensive approach to risk management. A significant achievement was implementing governance risk and compliance frameworks that improved adherence to regulatory standards by over 30%. Additionally, spearheading digital transformation initiatives not only integrated cutting-edge technologies but also boosted operational efficiency by 25%. Developing a proactive threat intelligence program transformed our incident response capabilities, reducing response times by an impressive 40%. Collaborating with various teams ensured that our cybersecurity strategies aligned seamlessly with business goals, ultimately providing a competitive advantage within the pharmaceutical industry. The journey has been about more than just security; it’s about enabling growth through secure digital environments. Competencies: Cybersecurity Strategy Development, Risk Management Frameworks, Digital Transformation Leadership, Threat Intelligence Programs

Responsible for leading the global HR function of the organisation. Alkem is an approx USD 1.5bn organisation with business in India, US, Australia, Chile and several other countries. It has more than 19000 employees on rolls, large salesforce, multiple manufacturing plants and R&D centre.